Class information for:
Level 1: MIZORIBINE//ORAL MIZORIBINE PULSE THERAPY//LS180 CELL

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
26970 240 20.0 66%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
236 3       ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS 48331
2798 2             LEFLUNOMIDE//MIZORIBINE//DIHYDROOROTATE DEHYDROGENASE 3097
26970 1                   MIZORIBINE//ORAL MIZORIBINE PULSE THERAPY//LS180 CELL 240

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MIZORIBINE authKW 6947537 38% 59% 92
2 ORAL MIZORIBINE PULSE THERAPY authKW 381692 1% 100% 3
3 LS180 CELL authKW 290809 2% 57% 4
4 CLINICAL PHARMACOKINETIC TRIAL authKW 254461 1% 100% 2
5 KIDNEY PEDIAT address 254461 1% 100% 2
6 MIZORIBINE INTERMITTENT PULSE THERAPY authKW 254461 1% 100% 2
7 MIZORIBINE ORAL PULSE THERAPY authKW 254461 1% 100% 2
8 HIGH DOSE MIZORIBINE authKW 169639 1% 67% 2
9 HISTOLOGIC PROGRESSION authKW 163579 1% 43% 3
10 NONLINEAR MIXED EFFECTS MODEL NONMEM authKW 163579 1% 43% 3

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Transplantation 6477 34% 0% 82
2 Immunology 1210 35% 0% 83
3 Surgery 794 32% 0% 76
4 Urology & Nephrology 627 15% 0% 37
5 Rheumatology 299 7% 0% 16
6 Pharmacology & Pharmacy 178 18% 0% 43
7 Pediatrics 153 10% 0% 23
8 Medicine, Research & Experimental 31 5% 0% 13
9 Cell & Tissue Engineering 16 1% 0% 2
10 Chemistry, Medicinal 4 2% 0% 5

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 KIDNEY PEDIAT 254461 1% 100% 2
2 HLTH CARE BUSINESS ADM 127231 0% 100% 1
3 KIDNEY CARE UNITHIGASHI KU 127231 0% 100% 1
4 MAJOURS MED SCI 127231 0% 100% 1
5 NEPHROL BONE METAB 127231 0% 100% 1
6 PEDIAT NEPHROLOTA KU 127231 0% 100% 1
7 PHARMACEUT SCI AFFAIRS 127231 0% 100% 1
8 STATE PHARMACEUTIAL BIOTECHNOL 127231 0% 100% 1
9 TRANSPLANT SURG KIDNEY 127231 0% 100% 1
10 VACULAR BIOL 127231 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MODERN RHEUMATOLOGY 11996 5% 1% 11
2 DRUG METABOLISM AND PHARMACOKINETICS 11278 3% 1% 8
3 TRANSPLANTATION PROCEEDINGS 11112 25% 0% 59
4 JAPANESE JOURNAL OF EXPERIMENTAL MEDICINE 9902 3% 1% 6
5 PEDIATRICS INTERNATIONAL 7313 6% 0% 14
6 CLINICAL AND EXPERIMENTAL NEPHROLOGY 3054 2% 0% 5
7 BIOLOGICAL & PHARMACEUTICAL BULLETIN 1469 4% 0% 10
8 PEDIATRIC NEPHROLOGY 1335 3% 0% 8
9 CLINICAL NEPHROLOGY 1255 3% 0% 7
10 NEPHRON EXPERIMENTAL NEPHROLOGY 1010 1% 0% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 MIZORIBINE 6947537 38% 59% 92 Search MIZORIBINE Search MIZORIBINE
2 ORAL MIZORIBINE PULSE THERAPY 381692 1% 100% 3 Search ORAL+MIZORIBINE+PULSE+THERAPY Search ORAL+MIZORIBINE+PULSE+THERAPY
3 LS180 CELL 290809 2% 57% 4 Search LS180+CELL Search LS180+CELL
4 CLINICAL PHARMACOKINETIC TRIAL 254461 1% 100% 2 Search CLINICAL+PHARMACOKINETIC+TRIAL Search CLINICAL+PHARMACOKINETIC+TRIAL
5 MIZORIBINE INTERMITTENT PULSE THERAPY 254461 1% 100% 2 Search MIZORIBINE+INTERMITTENT+PULSE+THERAPY Search MIZORIBINE+INTERMITTENT+PULSE+THERAPY
6 MIZORIBINE ORAL PULSE THERAPY 254461 1% 100% 2 Search MIZORIBINE+ORAL+PULSE+THERAPY Search MIZORIBINE+ORAL+PULSE+THERAPY
7 HIGH DOSE MIZORIBINE 169639 1% 67% 2 Search HIGH+DOSE+MIZORIBINE Search HIGH+DOSE+MIZORIBINE
8 HISTOLOGIC PROGRESSION 163579 1% 43% 3 Search HISTOLOGIC+PROGRESSION Search HISTOLOGIC+PROGRESSION
9 NONLINEAR MIXED EFFECTS MODEL NONMEM 163579 1% 43% 3 Search NONLINEAR+MIXED+EFFECTS+MODEL+NONMEM Search NONLINEAR+MIXED+EFFECTS+MODEL+NONMEM
10 ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY AGAINST MYELOPEROXIDASE 127231 0% 100% 1 Search ANTI+NEUTROPHIL+CYTOPLASMIC+ANTIBODY+AGAINST+MYELOPEROXIDASE Search ANTI+NEUTROPHIL+CYTOPLASMIC+ANTIBODY+AGAINST+MYELOPEROXIDASE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 KAWASAKI, Y , (2009) MIZORIBINE: A NEW APPROACH IN THE TREATMENT OF RENAL DISEASE.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - 26 96% 26
2 FUKE, T , ABE, Y , HIBINO, S , TAKESHI, M , SAITO, T , SAKURAI, S , WATANABE, S , MURAYAMA, JI , ITABASHI, K , NAKANO, Y , (2012) MIZORIBINE REQUIRES INDIVIDUAL DOSING DUE TO VARIATION OF BIOAVAILABILITY.PEDIATRICS INTERNATIONAL. VOL. 54. ISSUE 6. P. 885-891 22 85% 2
3 TANAKA, H , TSURUGA, K , IMAIZUMI, T , (2015) MIZORIBINE IN THE TREATMENT OF PEDIATRIC-ONSET GLOMERULAR DISEASE.WORLD JOURNAL OF PEDIATRICS. VOL. 11. ISSUE 2. P. 108 -112 25 64% 0
4 KANEDA, H , SHIMIZU, M , OHTA, K , USHIJIMA, K , GOTOH, Y , SATOMURA, K , NAGAI, T , FUJIEDA, M , MOROOKA, M , YAMADA, T , ET AL (2016) POPULATION PHARMACOKINETICS OF MIZORIBINE IN PEDIATRIC PATIENTS WITH KIDNEY DISEASE.CLINICAL AND EXPERIMENTAL NEPHROLOGY. VOL. 20. ISSUE 5. P. 757 -763 17 81% 0
5 ISHIDA, H , TAKAHARA, S , AMADA, N , TOMIKAWA, S , CHIKARAISHI, T , TAKAHASHI, K , UCHIDA, K , AKIYAMA, T , TANABE, K , TOMA, H , (2016) A PROSPECTIVE RANDOMIZED, COMPARATIVE TRIAL OF HIGH-DOSE MIZORIBINE VERSUS MYCOPHENOLATE MOFETIL IN COMBINATION WITH TACROLIMUS AND BASILIXIMAB FOR LIVING DONOR RENAL TRANSPLANT: A MULTICENTER TRIAL.EXPERIMENTAL AND CLINICAL TRANSPLANTATION. VOL. 14. ISSUE 5. P. 518 -525 13 100% 0
6 ICHINOSE, K , ORIGUCHI, T , KAWASHIRI, S , IWAMOTO, N , FUJIKAWA, K , ARAMAKI, T , KAMACHI, M , ARIMA, K , TAMAI, M , NAKAMURA, H , ET AL (2010) EFFICACY AND SAFETY OF MIZORIBINE BY ONE SINGLE DOSE ADMINISTRATION FOR PATIENTS WITH RHEUMATOID ARTHRITIS.INTERNAL MEDICINE. VOL. 49. ISSUE 20. P. 2211 -2218 14 100% 9
7 KAJI, H , MAIGUMA, T , INUKAI, Y , ONO, H , TANIGUCHI, R , MAKINO, K , TAGAWA, Y , TESHIMA, D , (2005) A SIMPLE DETERMINATION OF MIZORIBINE IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY WITH UV DETECTION.JOURNAL OF AOAC INTERNATIONAL. VOL. 88. ISSUE 4. P. 1114-1117 15 100% 1
8 ZHANG, M , XING, CY , LIU, J , (2013) STUDY OF THE EFFICACY OF MIZORIBINE IN LUPUS NEPHRITIS IN CHINESE PATIENTS.RHEUMATOLOGY INTERNATIONAL. VOL. 33. ISSUE 11. P. 2737 -2742 14 78% 2
9 CHOI, SJ , HUR, HJ , LEE, SB , CHOI, MS , KUH, HJ , SHIN, YH , LEE, HJ , (2008) A SIMPLE HPLC METHOD FOR THE QUANTIFICATION OF MIZORIBINE IN HUMAN SERUM: PHARMACOKINETIC APPLICATIONS.BIOMEDICAL CHROMATOGRAPHY. VOL. 22. ISSUE 11. P. 1259-1264 12 100% 1
10 ZHANG, X , FU, SX , HAN, S , ZHENG, XY , WANG, LM , (2013) THE ARGUMENT FOR THE USE OF MIZORIBINE IN RENAL TRANSPLANTATION: A META-ANALYSIS AND SYSTEMIC REVIEW.TRANSPLANT IMMUNOLOGY. VOL. 28. ISSUE 2-3. P. 106-111 17 61% 1

Classes with closest relation at Level 1


Rank Class id link
1 20983 DEOXYSPERGUALIN//15 DEOXYSPERGUALIN//AXE IMMUNOL
2 10938 TIAZOFURIN//IMPDH//BENZAMIDE RIBOSIDE
3 31961 COMPARAT TRANSPLANTAT//ANIM OURCES PROJECT//CLIN TRANSPLANAT SURG
4 4284 MYCOPHENOLIC ACID//MYCOPHENOLATE MOFETIL//MYCOPHENOLIC ACID GLUCURONIDE
5 30937 INNER BLOOD RETINAL BARRIER//PROTON COUPLED ORGANIC CATION ANTIPORTER//RETINAL CAPILLARY ENDOTHELIAL CELLS
6 34850 CEFADROXIL INTESTINAL ABSORPTION//CAS 50370 12 2//QUINOLONE ANTIMICROBIAL AGENT
7 2712 LUPUS NEPHRITIS//SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS
8 32961 UNIDAD 307//ADJUSTED SUBDIFFERENTIALS//BANDED PALM CIVET HEMIGALUS DERBYANUS
9 33973 MDR I//RHEUMATOLOTA KU//BIOLOGIC AGENT THERAPY
10 5164 TACROLIMUS//FK506//TRANSPLANTATION PROCEEDINGS

Go to start page